[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@SiphonCapital Avatar @SiphonCapital Preston

Preston posts on X about $unh, unh, $nvo, dont get the most. They currently have XX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks finance countries

Social topic influence $unh #16, unh, $nvo, dont get, stay in, vix, trust in, money, have fun, $vix

Top assets mentioned UnitedHealth Group (UNH) Novo-Nordisk (NVO) Vixco (VIX) Eos Energy Enterprises, Inc. (EOSE) Eli Lilly and Company (LLY)

Top Social Posts #

Top posts by engagements in the last XX hours

"Note to self. Dont get lost in the sauce. This is the way life is. Dont have the player(s). Hate the game. Keep doing your thing. Stay in your lane. Flourish. $UNH"
X Link @SiphonCapital 2025-10-12T16:36Z XX followers, XXX engagements

"Making me feel better about my decisions. I fully trust in Hemsley turning around $UNH. This quarter will be about cutting cost and breaking even. Next year is when we see the money come and 2027 will be accelerated. Have fun"
X Link @SiphonCapital 2025-10-11T22:48Z XX followers, XXX engagements

"@YeahDrDave the brochure does not explicitly state or confirm that the Robena Mega Site will use Eos Energy Enterprises ($EOSE) battery technology for its XXX MW / 1820 MWh storage system"
X Link @SiphonCapital 2025-10-05T21:52Z XX followers, XX engagements

"@FibsDontFib No way really"
X Link @SiphonCapital 2025-10-13T14:12Z XX followers, XX engagements

"$NVO falls from grace and the quiet setup for a 2026 comeback. A deep dive into Novo Nordisks decline its upcoming Wegovy-in-a-pill strategy and how its parent company is quietly building Denmarks biotech-quantum future. After dominating with Ozempic and Wegovy $NVO was blindsided by: Rapid telehealth adoption fueling generic copycats Supply chain bottlenecks And competitor $LLY sprinting ahead with Zepbound + its own oral pill. Novo Nordisk once the markets golden child of GLP-1s has lost nearly XX% YTD giving back all of its 2023 gains. But beneath the surface a strategic reset is taking"
X Link @SiphonCapital 2025-10-05T01:19Z XX followers, 3090 engagements

"@11thestate @grok find me the source"
X Link @SiphonCapital 2025-10-05T23:20Z XX followers, XXX engagements

"@nicrypto The marketing stopped working"
X Link @SiphonCapital 2025-10-14T16:00Z XX followers, XXX engagements

"Weaknesses & Risks 2025 underpricing in Medicare Advantage (margins sharply lower). Optum Health profitability reset after overexpansion. Lingering cybersecurity & reputational risk from Change attack. Ongoing regulatory headwinds: MA rate cuts PBM reform antitrust scrutiny"
X Link @SiphonCapital 2025-10-11T14:12Z XX followers, XX engagements

"@ZaStocks $UNH"
X Link @SiphonCapital 2025-10-13T12:30Z XX followers, XXX engagements

"@DeepIceValue Still unsure about $NVO. I like that they've listened and are cutting back on R&D. The business needs restructuring. Waiting until 2026. Wegovy-in-a-pill should give an edge. Hoping for minimal side effects"
X Link @SiphonCapital 2025-10-12T13:50Z XX followers, XX engagements

"Unbothered Novel Honing $UNH"
X Link @SiphonCapital 2025-10-12T12:06Z XX followers, XXX engagements

"$UNH Optum Insight UnitedHealths tech data and revenue enablement arm is essentially the rails software and services behind U.S. healthcare transactions. Think clearinghouse APIs revenue-cycle tools payment integrity InterQual guidelines and multi-year managed services. 🧵 Scale today: 2024 revenue came in at $18.8B (1% YoY) due to the Change outage with operating earnings of $3.1B (adj. $4.4B) and a $32.8B backlog ($19.8B expected next XX months $12.5B affiliated). Thats high-visibility multi-year revenue. By Q2 2025 Optum Insight had rebounded: $4.8B revenue (+6% YoY) XXXX% margin and"
X Link @SiphonCapital 2025-10-11T15:25Z XX followers, XXX engagements

"Novo now plans to fight back launching a Wegovy-in-a-pill by early 2026 pending FDA approval. Itll debut through telehealth partners like @ro and @ww_us mirroring the platforms that helped the copycats spread. Novos U.S. chief says theyre exploring a subscription model 6- to 12-month signups at discounted prices. Think of it as a SaaS-style model for obesity medications: predictable revenue reduced churn and improved compliance. Even with the pullback GLP-1 remains the most disruptive pharma market since statins. Analysts still forecast $100B TAM by 2030. But competition is fierce and Lilly"
X Link @SiphonCapital 2025-10-05T01:19Z XX followers, XXX engagements

"Extend the ACA pretty please 🥺 $UNH"
X Link @SiphonCapital 2025-10-14T19:10Z XX followers, 1235 engagements

"Tariffs are just a hiccup. $UNH will succeed. Hemsley should be studied more tbh. Everything they mentioned in their last earnings call has been directly addressed in the past two months. Optum Insight is accelerating within India. iykyk"
X Link @SiphonCapital 2025-10-11T16:38Z XX followers, 1783 engagements

"Last week it teamed up with the Danish government to support a XXX million quantum technology fund led by XX North. That comes just a year after the Novo Nordisk Foundation and Denmark co-funded an Nvidia-powered supercomputer for drug R&D. This is more than PR. Its part of Denmarks long-term industrial strategy to: Strengthen biotech and life science computation Build sovereign AI and quantum infrastructure Reduce reliance on U.S. hyperscalers and cloud monopolies. For Novo Holdings its strategic. Theyre effectively building the next-generation tech stack for drug discovery quantum AI and"
X Link @SiphonCapital 2025-10-05T01:19Z XX followers, XXX engagements

"Big picture: UnitedHealth is tightening its operations re-pricing MA plans and rebuilding trust after the cyberattack. If execution improves UNH could re-rate toward fair value as margin recovery plays out through 2026"
X Link @SiphonCapital 2025-10-11T14:12Z XX followers, XX engagements

"Probably nothing. Probably something. Increased spending but analysts say theyre underwater. Make it make sense. Also $UNH is pushing more ads related to Medicare advantage. 🤔"
X Link @SiphonCapital 2025-10-11T18:17Z XX followers, 1034 engagements

"This is why $UNH"
X Link @SiphonCapital 2025-10-14T10:41Z XX followers, 1923 engagements

"@RentYourStocks @brent_e_trader Whats diversifying Never heard of her. $UNH should be at $XXX rn"
X Link @SiphonCapital 2025-10-11T16:31Z XX followers, XXX engagements

Category Creators

https://lunarcrush.com/api4/public/category/:category/creators/v1

Get the top creators for a social category

input parameters:

Example request:

curl -H "Authorization: Bearer <API_KEY>" https://lunarcrush.com/api4/public/category/musicians/creators/v1

Example response:

{
  "data": [
    {
      "creator_id": "twitter::79293791",
      "creator_name": "rihanna",
      "creator_avatar": "https://pbs.twimg.com/profile_images/1960786225423659008/GhLekHuP_200x200.jpg",
      "creator_followers": 107096627,
      "creator_rank": 1,
      "interactions_24h": 86230220
    }
  ]
}

Schema:

Creators List

https://lunarcrush.com/api4/public/creators/list/v1

Get a list of trending social creators over all of social based on interactions. To get lists of creators by category or topic see the topics and categories endpoints.

Example request:

curl -H "Authorization: Bearer <API_KEY>" https://lunarcrush.com/api4/public/creators/list/v1

Example response:

{
  "data": [
    {
      "creator_name": "FoxNews",
      "creator_display_name": "Fox News",
      "creator_id": "1367531",
      "creator_network": "twitter",
      "creator_avatar": "https://pbs.twimg.com/profile_images/1956414642370015232/GEq5Z9jN_200x200.png",
      "creator_followers": 208065784,
      "creator_posts": 1946,
      "creator_rank": 1,
      "interactions_24h": 303150257
    }
  ]
}

Schema:

Creator

https://lunarcrush.com/api4/public/creator/:network/:id/v1

Get detail information on a specific creator

input parameters:

Example request:

curl -H "Authorization: Bearer <API_KEY>" https://lunarcrush.com/api4/public/creator/twitter/elonmusk/v1

Example response:

{
  "data": {
    "creator_id": "twitter::44196397",
    "creator_name": "elonmusk",
    "creator_display_name": "Elon Musk",
    "creator_avatar": "https://pbs.twimg.com/profile_images/1936002956333080576/kqqe2iWO_200x200.jpg",
    "creator_followers": 226637736,
    "creator_rank": 26,
    "interactions_24h": 53318135,
    "topic_influence": [
      {
        "topic": "elon musk",
        "count": 180,
        "percent": 2.81,
        "rank": X
      }
    ],
    "top_community": [
      {
        "creator_name": "grok",
        "creator_display_name": "Grok",
        "creator_avatar": "https://pbs.twimg.com/profile_images/1893219113717342208/Vgg2hEPa_200x200.jpg",
        "count": XXX
      }
    ]
  }
}

Schema:

Creator Time Series

https://lunarcrush.com/api4/public/creator/:network/:id/time-series/v1

Get time series data on a creator.

input parameters:

Example request:

curl -H "Authorization: Bearer <API_KEY>" https://lunarcrush.com/api4/public/creator/twitter/lunarcrush/time-series/v1

Example response:

{
  "config": {
    "network": "twitter",
    "influencer_id": "twitter::988992203568562176",
    "interval": "1w",
    "start": 1758153600,
    "end": 1758844800,
    "bucket": "hour",
    "name": "lunarcrush",
    "remote_api": "danode2-13",
    "generated": 1758826398
  },
  "data": [
    {
      "time": 1758153600,
      "followers": 309352,
      "interactions": 1758,
      "posts_active": 29,
      "posts_created": 1,
      "creator_rank": 296332
    }
  ]
}

Schema: